观察鲑鱼降钙素对于维持性血液透析并发肾性骨病患者的临床治疗效果

Clinical Effect of Salmon Calcitonin for Maintenance Hemodialysis Patients With Renal Osteodystrophy

目的研究鲑鱼降钙素对于维持性血液透析并发肾性骨病患者的临床治疗效果。方法选取我院收治的维持性血液渗透并发肾性骨病的患者100例作为研究对象,将其随机分为两组,对照组给予常规方法 ,观察组患者在此基础上给予鲑鱼降钙素进行治疗,比较临床疗效。结果观察组患者治疗后的生化指标的变化以及临床症状改善情况均显著优于对照组,且比较有统计学差异(P<0.05)。结论在常规治疗的基础上给予鲑鱼降钙素治疗维持性血液透析并发肾性骨病的患者,能有效改善患者的临床症状,效果显著。

Objective To study the clinical outcomes of salmon calcitonin for hemodialysis patients with renal osteodystrophy. Methods 100 patients with hemodialysis and renal osteodystrophy were randomly divided into two groups, the control group received conventional method, the observation group were treated with salmon calcitonin treatment, compare the clinical efficacy. Results The changes and clinical symptoms observed in patients after treatment of biochemical indicators in observation were significantly better than the control group, there was statistical difference （P〈0.05）. Conclusion Salmon calcitonin can effectively improve the clinical symptoms of patients with renal osteodystrophy..